TVRD CIK: 1346830

Tvardi Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
23.0
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−89.1
FY22:
−87.5
FY23:
−121
FY24:
−58.4
FY25:
−26.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−88.2
FY22:
–
FY23:
–
FY24:
–
FY25:
−26.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−88.4
FY22:
−85.5
FY23:
−119
FY24:
−71.3
FY25:
−18.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−88.4
FY22:
−85.5
FY23:
−119
FY24:
−70.9
FY25:
−18.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data